Aimei Health Technology Co., Ltd. is a leading innovator in the healthcare sector, dedicated to improving patient care via advanced technology and innovative health solutions. Specializing in the development and production of state-of-the-art medical devices and integrated health management systems, the company focuses on enhancing patient outcomes and optimizing healthcare delivery. With a strong commitment to research and development, strategic partnerships, and a proactive approach to market dynamics, Aimei is well-positioned for long-term growth in the evolving global healthcare landscape.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -1.08% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-1.32 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -43.40% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $1.44M |
| % Insiders | 0.00% |
| % Institutions | 0.07% |